Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Update Il y a 4 ans
Reference: NCT00984282

Woman and Man

Extract

Trial of sorafenib versus placebo in the treatment of locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine


Inclusion criteria

  • Thyroid Neoplasms


Links